These results suggest that sHLA-G expression levels could be useful to discriminate between cancer precursor diseases and benign pathologies, and that those hyperplastic and adenomatous gastric polyps should be subjected to continued surveillance to ensure that supervening carcinoma be detected at the earliest possible phase. The gene discussed is HLA-G; the disease is cancer.